Yangyang Wang (642852)
102  Ergebnisse:
Personensuche X
?
1

The common targets of curcumin and IS:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/journal_contribution/The_common_targets_of_curcumin_and_IS_/21816836.  , 2023
 
?
2

Fig 5 -:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/figure/Fig_5_-/21816854.  , 2023
 
?
3

Fig 2 -:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/figure/Fig_2_-/21816845.  , 2023
 
?
4

Table2_AGREE II for TCM: Tailored to evaluate methodologica..:

Xiuli Xie (5144024) ; Yangyang Wang (642852) ; Hui Li (32376)
https://figshare.com/articles/dataset/Table2_AGREE_II_for_TCM_Tailored_to_evaluate_methodological_quality_of_TCM_clinical_practice_guidelines_docx/21875625.  , 2023
 
?
5

Image_1_Comparison of first-line treatments for elderly pat..:

Yangyang Wang (642852) ; Xiyang Ren (14324529) ; Keke Huang (703621)...
https://figshare.com/articles/figure/Image_1_Comparison_of_first-line_treatments_for_elderly_patients_with_diffuse_large_B-cell_lymphoma_A_systematic_review_and_network_meta-analysis_tif/21811737.  , 2023
 
?
6

Table3_AGREE II for TCM: Tailored to evaluate methodologica..:

Xiuli Xie (5144024) ; Yangyang Wang (642852) ; Hui Li (32376)
https://figshare.com/articles/dataset/Table3_AGREE_II_for_TCM_Tailored_to_evaluate_methodological_quality_of_TCM_clinical_practice_guidelines_DOCX/21875628.  , 2023
 
?
7

Table4_AGREE II for TCM: Tailored to evaluate methodologica..:

Xiuli Xie (5144024) ; Yangyang Wang (642852) ; Hui Li (32376)
https://figshare.com/articles/dataset/Table4_AGREE_II_for_TCM_Tailored_to_evaluate_methodological_quality_of_TCM_clinical_practice_guidelines_docx/21875631.  , 2023
 
?
8

Fig 3 -:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/figure/Fig_3_-/21816848.  , 2023
 
?
9

The binding mode of curcumin and 5 Targets:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/figure/The_binding_mode_of_curcumin_and_5_Targets_/21816857.  , 2023
 
?
10

The top 20 pathways of KEGG enrichment analysis:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/journal_contribution/The_top_20_pathways_of_KEGG_enrichment_analysis_/21816839.  , 2023
 
?
11

Docking results of curcumin with key target molecules:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/dataset/Docking_results_of_curcumin_with_key_target_molecules_/21816878.  , 2023
 
?
12

The top 10 curcumin–IS candidate key targets according degr..:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/dataset/The_top_10_curcumin_IS_candidate_key_targets_according_degree_/21816875.  , 2023
 
?
13

Table1_AGREE II for TCM: Tailored to evaluate methodologica..:

Xiuli Xie (5144024) ; Yangyang Wang (642852) ; Hui Li (32376)
https://figshare.com/articles/dataset/Table1_AGREE_II_for_TCM_Tailored_to_evaluate_methodological_quality_of_TCM_clinical_practice_guidelines_DOCX/21875619.  , 2023
 
?
14

RMSF of the complex:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/figure/RMSF_of_the_complex_/21816863.  , 2023
 
?
15

AGE-RAGE signaling pathway in diabetic complications:

Yangyang Wang (642852) ; Guoxiu Zu (14328977) ; Ying Yu (7066)...
https://figshare.com/articles/figure/AGE-RAGE_signaling_pathway_in_diabetic_complications_/21816851.  , 2023
 
1-15